Drug Discovery · Newton, MA · Founded 2015 · Privately Held (backing)
Developer of immunomodulatory therapeutics designed for treating both autoimmunity and cancer. Abcuro is based in Newton, MA and was founded in 2015. It was valued at $700 million at its later-stage round in Feb 2025, the last priced event on record. It has raised $407 million across 5 recorded rounds; the latest was a $200 million Series C in Feb 2025.
PMV mark · valuation
$700.0M
Oct 2026
Priced at
its later-stage round
Feb 2025
Total raised
$407.3M
Last round
Later Stage VC (Series C)
Feb 2025
Team — not yet on record
No current team members for Abcuro are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Abcuro with a free account
·The complete investor list: 20 names
·Watch Abcuro: the Monday email on marks, rounds and moves
